South African billionaire Johann Rupert has secured regulatory approval for one of the country’s largest healthcare transactions in recent years, strengthening his control over a network of 50 hospitals and nearly 9,000 beds as debate intensifies around the future of private healthcare under South Africa’s proposed National Health Insurance (NHI) system, according to Business Insider Africa and Billionaires Africa. The Competition Tribunal has approved Remgro’s acquisition of full ownership of Mediclinic Southern Africa, clearing a key hurdle in a transaction valued at approximately $950 million (R16.2 billion). The deal gives Rupert’s investment group direct control of one of the region’s largest private healthcare operators.
Under the restructuring agreement, Remgro will assume 100 percent ownership of Mediclinic Southern Africa, while its joint venture partner, Investment Holding Limited (IHL), a subsidiary of Mediterranean Shipping Company (MSC), will take full control of Switzerland’s Hirslanden hospital group. Mediclinic Southern Africa operates 50 hospitals, 15 day clinics, six mental health facilities, six sub-acute facilities, and approximately 8,991 licensed beds, in addition to controlling the Intercare healthcare network and ER24 emergency medical services. The transaction effectively unwinds the 50-50 ownership structure established when Remgro and MSC jointly acquired Mediclinic in 2023.
The approval comes at a pivotal moment for South Africa’s healthcare sector as policymakers continue discussions around the implementation of the National Health Insurance framework, which aims to expand access to healthcare while reshaping the relationship between public and private providers. Healthcare operators are closely monitoring potential regulatory changes, reimbursement models, and market dynamics that could affect investment decisions across the sector. Remgro said full ownership will enable greater strategic focus, stronger local decision-making, and deeper engagement with patients, clinicians, and regulators in its core market.
For investors, the transaction underscores continued confidence in private healthcare as a long-term growth sector despite evolving regulatory uncertainty. Analysts note that South Africa’s ageing population, rising burden of chronic diseases, and growing demand for quality healthcare services continue to support investment in the sector. With Mediclinic already among Remgro’s largest earnings contributors, the acquisition further consolidates Rupert’s influence in one of Africa’s most important healthcare markets and positions the group to play a significant role in the industry’s next phase of development.
